Zhengming Jin

2.0k total citations
98 papers, 660 citations indexed

About

Zhengming Jin is a scholar working on Hematology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Zhengming Jin has authored 98 papers receiving a total of 660 indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Hematology, 36 papers in Oncology and 31 papers in Pathology and Forensic Medicine. Recurrent topics in Zhengming Jin's work include Lymphoma Diagnosis and Treatment (31 papers), Acute Myeloid Leukemia Research (29 papers) and Hematopoietic Stem Cell Transplantation (26 papers). Zhengming Jin is often cited by papers focused on Lymphoma Diagnosis and Treatment (31 papers), Acute Myeloid Leukemia Research (29 papers) and Hematopoietic Stem Cell Transplantation (26 papers). Zhengming Jin collaborates with scholars based in China, United States and Thailand. Zhengming Jin's co-authors include Depei Wu, Xiaowen Tang, Huiying Qiu, Yue Han, Aining Sun, Depei Wu, Miao Miao, Zhengzheng Fu, Chengcheng Fu and Nana Ping and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Frontiers in Immunology.

In The Last Decade

Zhengming Jin

89 papers receiving 651 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhengming Jin China 15 325 270 162 127 124 98 660
Vladan Vučinić Germany 18 518 1.6× 333 1.2× 172 1.1× 230 1.8× 177 1.4× 105 934
Tiffaney L. Vincent United States 11 441 1.4× 221 0.8× 444 2.7× 156 1.2× 219 1.8× 20 954
Delia Dima Romania 16 240 0.7× 173 0.6× 70 0.4× 118 0.9× 255 2.1× 70 645
Kerstin Schäfer‐Eckart Germany 11 513 1.6× 176 0.7× 217 1.3× 84 0.7× 134 1.1× 33 764
Marco Cerrano Italy 11 293 0.9× 133 0.5× 74 0.5× 62 0.5× 151 1.2× 43 465
Jörg Faber Germany 11 109 0.3× 192 0.7× 72 0.4× 106 0.8× 144 1.2× 31 466
Kang Howson‐Jan Canada 12 404 1.2× 203 0.8× 56 0.3× 117 0.9× 137 1.1× 33 666
Michel Delforge Belgium 17 716 2.2× 509 1.9× 65 0.4× 113 0.9× 486 3.9× 111 1.0k
B. Pignon France 13 429 1.3× 285 1.1× 170 1.0× 78 0.6× 208 1.7× 44 832
Rose Beck United States 14 172 0.5× 262 1.0× 49 0.3× 266 2.1× 149 1.2× 49 699

Countries citing papers authored by Zhengming Jin

Since Specialization
Citations

This map shows the geographic impact of Zhengming Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhengming Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhengming Jin more than expected).

Fields of papers citing papers by Zhengming Jin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhengming Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhengming Jin. The network helps show where Zhengming Jin may publish in the future.

Co-authorship network of co-authors of Zhengming Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Zhengming Jin. A scholar is included among the top collaborators of Zhengming Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhengming Jin. Zhengming Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Dan, Weixiang Lu, Zhengming Jin, et al.. (2025). Characteristics of second primary malignancies following bispecific antibodies therapy. Journal for ImmunoTherapy of Cancer. 13(4). e011200–e011200. 3 indexed citations
2.
Zhao, Weili, Jun Zhu, Yuqin Song, et al.. (2024). Tucidinostat plus R-CHOP in previously untreated diffuse large B-cell lymphoma with double expression of MYC and BCL2: An interim analysis from the phase III DEB study.. Journal of Clinical Oncology. 42(17_suppl). LBA7003–LBA7003. 7 indexed citations
3.
Qu, Changju, Hailing Liu, Rui Zou, et al.. (2023). P1196: ORIENT STUDY: REGIMEN OF ORELABRUTINIB PLUS R-CHOP-LIKE FOR PATIENTS WITH NEWLY DIAGNOSED UNTREATED NON-GCB DLBCL. HemaSphere. 7(S3). e918465b–e918465b. 1 indexed citations
4.
5.
He, Jiajie, Rui Zou, Liqing Kang, et al.. (2023). Circulating tumor DNA determining hyperprogressive disease after CAR-T therapy alarms in DLBCL: a case report and literature review. Frontiers in Oncology. 13. 1283194–1283194.
6.
Gu, Jingxian, Sining Liu, Wei Cui, et al.. (2022). Identification of the Predictive Models for the Treatment Response of Refractory/Relapsed B-Cell ALL Patients Receiving CAR-T Therapy. Frontiers in Immunology. 13. 858590–858590. 6 indexed citations
7.
8.
Li, Xuewei, Nana Ping, Yong Wang, et al.. (2021). Case Report: A Case With Philadelphia Chromosome Positive T-Cell Lymphoblastic Lymphoma and a Review of Literature. Frontiers in Oncology. 10. 584149–584149. 5 indexed citations
9.
Liu, Limin, Yanming Zhang, Huifen Zhou, et al.. (2020). Combination of haploidentical haematopoietic stem cell transplantation with an unrelated cord-blood unit in patients with severe aplastic anemia: a report of 146 cases. Bone Marrow Transplantation. 55(10). 2017–2025. 12 indexed citations
10.
Huang, Chenrong, Fan Xia, Ling Xue, et al.. (2019). Coadministration of vindesine with high-dose methotrexate therapy increases acute kidney injury via BCRP, MRP2, and OAT1/OAT3. Cancer Chemotherapy and Pharmacology. 85(2). 433–441. 12 indexed citations
11.
Liu, Limin, Shan Liu, Yanming Zhang, et al.. (2019). Excellent Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Paroxysmal Nocturnal Hemoglobinuria: A Single-Center Study. Biology of Blood and Marrow Transplantation. 25(8). 1544–1549. 12 indexed citations
12.
13.
Tian, Hong, Yang Xu, Liming Liu, et al.. (2016). Comparison of outcomes in mixed phenotype acute leukemia patients treated with chemotherapy and stem cell transplantation versus chemotherapy alone. Leukemia Research. 45. 40–46. 26 indexed citations
14.
Gao, Su, Zheng Li, Jianhong Fu, et al.. (2015). Decitabine in the Treatment of Acute Myeloid Leukemia and Myelodysplastic Syndromes, Which Combined with Complex Karyotype Respectively. Asian Pacific Journal of Cancer Prevention. 16(15). 6627–6632. 9 indexed citations
15.
Wang, Xiuli, Song Jin, Limin Liu, et al.. (2014). [Efficacies of hematopoietic stem cell transplantation for severe aplastic anemia: a report of 43 patients].. PubMed. 94(40). 3140–4. 1 indexed citations
16.
17.
18.
He, Guangsheng, Xiang Zhang, Depei Wu, et al.. (2009). Outcomes of CAG Regimen for Refractory Biphenotypic Acute Leukemia Patients. Chinese Medical Sciences Journal. 24(3). 178–181. 4 indexed citations
19.
Jin, Zhengming, Yun Zhang, Jun-zhu Chen, Jian‐Hua Zhu, & Furong Zhang. (2006). [Investigation on levels of serum lipids among 602 patients who had undergone coronary angiography in Zheijian province].. PubMed. 27(10). 897–900. 1 indexed citations
20.
Jin, Zhengming, Yun Zhang, Jun-zhu Chen, et al.. (2006). Study of the correlation between blood lipid levels and the severity of coronary atherosclerosis in a Chinese population sample. Acta Cardiologica. 61(6). 603–606. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vladan Vučinić Breakdown of academic impact, for papers by Tiffaney L. Vincent Breakdown of academic impact, for papers by Delia Dima Breakdown of academic impact, for papers by Kerstin Schäfer‐Eckart Breakdown of academic impact, for papers by Marco Cerrano Breakdown of academic impact, for papers by Jörg Faber Breakdown of academic impact, for papers by Kang Howson‐Jan Breakdown of academic impact, for papers by Michel Delforge Breakdown of academic impact, for papers by B. Pignon Breakdown of academic impact, for papers by Rose Beck
Rankless by CCL
2026